Patients with CTD-PAH had higher B-type natriuretic peptide (BNP) levels and lower diffusing capacity of carbon monoxide (DLCO) but lower mPAP levels than those of iPAH patients. This evidence concerns the gene NPPB and idiopathic pulmonary arterial hypertension.